Article Text

PDF
Longitudinal course of depression symptoms in multiple sclerosis
  1. P A Arnett1,
  2. J J Randolph2
  1. 1Department of Psychology, Penn State University, University Park, Pennsylvania, USA
  2. 2Department of Psychiatry, Dartmouth Medical School, Lebanon, New Hampshire, USA
  1. Correspondence to:
 Dr Peter Arnett
 Penn State University, Psychology Department, 522 Bruce V Moore Bldg, University Park, PA 16802-3105, USA; paa6{at}psu.edu

Abstract

Background: Despite the high lifetime prevalence of depression in multiple sclerosis (MS), its longitudinal course is poorly understood.

Objective: To examine the longitudinal course of and reliable change in different depression symptom clusters in MS, and the longitudinal association of interferon beta treatment and coping with depression symptoms.

Methods: 53 MS patients were examined at two time points three years apart on the Beck Depression Inventory (BDI) and the Chicago Multiscale Depression Inventory (CMDI).

Results: Correlations from time 1 to time 2 for BDI, CMDI-total, CMDI-evaluative scale, and CMDI-vegetative scale were all highly significant, and reliable change indices reflected little change over time. In contrast, the correlation over time for the CMDI-mood scale was significantly lower (p<0.05) than the CMDI-evaluative and CMDI-vegetative scale correlations, and over 40% of patients showed reliable change. Patients who improved in their mood showed increased use of active coping, while patients who worsened showed decreased active coping strategies; the latter were also significantly more likely to have been taking interferon beta drugs at both time points than patients who did not change in their mood functioning.

Conclusions: Mood symptoms of depression are significantly more variable over time than neurovegetative or negative evaluative symptoms in MS patients. Decreased use of active coping strategies may put patients at risk of increased depressed mood, whereas increased use of active coping may result in decreased depressed mood longitudinally. Interferon beta use may put patients at risk of increases in depressed mood.

  • BDI, Beck Depression Inventory
  • CMDI, Chicago Multiscale Depression Inventory
  • EDSS, Expanded Disability Status Scale
  • MS, multiple sclerosis
  • multiple sclerosis
  • depression
  • coping
  • interferons

Statistics from Altmetric.com

Footnotes

  • 1 Degrees of freedom here are reduced because one participant did not complete the COPE at time 1 and another did not complete it at time 2. A third participant failed to complete at least half the items making up the active coping index, and a fourth participant completed less than half the questionnaire overall. As a result, these participants were excluded from the analyses.

  • Competing interests: none declared

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.